earnings
confidence high
sentiment positive
materiality 0.75
Adtalem Q3 FY2025 EPS $1.59 ($1.92 adj.), revenue $466.1M +12.9%; raises FY guidance
Covista Inc.
2025-Q3 EPS
reported $4.74
vs consensus $1.61
▲ beat
(+194.6%)
- Revenue $466.1M (+12.9% YoY); diluted EPS $1.59 (adj. $1.92, +28% YoY); net income $60.8M.
- Total enrollment up 9.8% to 94,223; Chamberlain +6.8%, Walden +13.5%, Med/Vet +1.2%.
- Completed $300M share repurchase program; new $150M authorization through May 2028.
- FY2025 guidance raised: revenue $1,760-1,775M, adj. EPS $6.40-$6.60 (28-32% YoY growth).
- Adjusted EBITDA $127.8M (+19.3% YoY); margin 27.4% vs 25.9% prior year.